Business
OWC Pharmaceutical Research to Present at Lyons Capital’s Wall Street Conference
OWC Pharmaceutical Research to Present at Lyons Capital’s Wall Street Conference.
About this update from Owc Pharmaceutical Research Corp
[{"type":"text","content":"\n\n\n\nOWC Pharmaceutical Research to Present at Lyons Capital’s Wall Street Conference\n\n\n\n\n\nOWC Pharmaceutical Research to Present at Lyons Capital’s Wall Street Conference\nIndustry Leader And OWC Advisory Board Member, Jeffrey Friedland, To Speak At The Conference And Introduce OWC Management\nPR Newswire\nPETACH TIKVA, Israel, February 17, 2017\n\n\n\nPETACH TIKVA, Israel, February 17, 2017 /PRNewswire/ --\n\nOWC Pharmaceutical Research Corp. (OTCQB: OWCP), (\"OWC\" or the \"Company\"), a developer of cannabinoid-based therapies targeting a variety of different medical conditions and disorders, today announced that it will be presenting at the Wall Street Conference. The event will be held at the Hilton Doubletree Hotel and Conference Center in Deerfield Beach/ Boca Raton, Florida, on Wednesday, March 1, 2017.\n\n     (Logo: http://mma.prnewswire.com/media/458036/OWC_Logo.jpg )\n\n\nThe Wall Street Conference is the premiere conference in the venture capital arena and small-cap marketplace. Conference participants include industry leaders from the hedge fund, investment banking, and private equity worlds, as well as sophisticated investors, who attend to discuss significant trends in the financial markets. \n\nZiv Turner, OWCP's VP Business development and Managing Director of One World Cannabis, the Company's wholly-owned subsidiary, will provide conference attendees with an update about the Company's progress, specifically focused on its research and products in development, and most importantly the Company's plans for the future, sales and marketing in the US, Canada and Europe this year (2017). The Company is currently scheduled to give its presentation on or around 3:30 PM, as a follow to its advisory board member, Mr. Jeffery Friedland's key tone session. Other management team members, Mr. Mordehai Bignitz, Chairman and CEO and Dr. Yehuda Baruch, Chief Science Officer will also be available for one-on-one discussions during the conference.\n\nMr. Turner commented on the Company's participation in the event, \"The Wall Street Conference is one of the leading conferences for small-cap investors and OWC is excited to be a part of it. OWC continues to make significant progress in the research and development of cannabis-centric medical treatments, specifically with our psoriasis ...